90 Real world data analysis of neoadjuvant Nivolumab in combination with platinum-based chemotherapy in operable non–small cell lung cancer (NSCLC). The Guy's cancer centre experience
Toki Maria , Elkhalifa Mohammed , Bille Andrea , Tan Carol , Ashrafian Leanne , Okiror Lawrence , Fraser Stephanie , Mclean Emma , Smith Daniel , Ahmed Shahreen , Skwarski Michael , Santis George , Ryanna Kimuli , Morton Cienne , Ghosh Sharmistha , Karapanagiotou Eleni , Gennatas Spyridon , Spicer James , Georgiou Alexandros
{"title":"90 Real world data analysis of neoadjuvant Nivolumab in combination with platinum-based chemotherapy in operable non–small cell lung cancer (NSCLC). The Guy's cancer centre experience","authors":"Toki Maria , Elkhalifa Mohammed , Bille Andrea , Tan Carol , Ashrafian Leanne , Okiror Lawrence , Fraser Stephanie , Mclean Emma , Smith Daniel , Ahmed Shahreen , Skwarski Michael , Santis George , Ryanna Kimuli , Morton Cienne , Ghosh Sharmistha , Karapanagiotou Eleni , Gennatas Spyridon , Spicer James , Georgiou Alexandros","doi":"10.1016/j.lungcan.2025.108200","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":18129,"journal":{"name":"Lung Cancer","volume":"200 ","pages":"Article 108200"},"PeriodicalIF":4.5000,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Lung Cancer","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0169500225001734","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
期刊介绍:
Lung Cancer is an international publication covering the clinical, translational and basic science of malignancies of the lung and chest region.Original research articles, early reports, review articles, editorials and correspondence covering the prevention, epidemiology and etiology, basic biology, pathology, clinical assessment, surgery, chemotherapy, radiotherapy, combined treatment modalities, other treatment modalities and outcomes of lung cancer are welcome.